- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07713355
The Impact of Multimodal Brain Monitoring on Postoperative Outcomes in Elderly Patients Undergoing Major Abdominal Surgery
Impact of Multimodal Brain Monitoring Under General Anesthesia on Postoperative Outcomes in Elderly Patients Undergoing Major Abdominal Surgery: A Multicenter, Prospective, Single-blind, Randomized Controlled Study
The purpose of this clinical trial is to investigate the effect of multimodal brain monitoring under general anesthesia on postoperative outcomes in elderly patients undergoing abdominal surgery.The research hypothesis is that multimodal brain monitoring under general anesthesia can reduce the incidence of postoperative composite complications and improve postoperative outcomes in elderly patients undergoing major abdominal surgery.
Eligible patients will be randomly assigned in a 1:1 ratio to the Multimodal Brain Monitoring under General Anesthesia Group (MBMGA group) and the Bispectral Index Monitoring under General Anesthesia Group (BIS group). The primary outcome is the postoperative composite complication rate . Secondary outcomes include intraoperative hyperglycemia, adverse events during anesthesia induction and maintanance, changes in blood pressure and heart rate, intraoperative hypotension, the dosage of perioperative anesthetics and vasoactive drugs, changes in serum cortisol, cardiac troponin I, blood creatinine (Cr) level, extubation time and awake time, the rate of transferring to ICU or AICU, The time to first use analgesia pump and the cumulative dose of postoperative oxycodone, systemic complications, hospitalization time, first exhaust time , first oral intake time, rate of second surgery and mortality within 30 days postoperatively.
Participants will:
- Undergo routine preoperative fasting for 6-8 hours;
- Prior to anesthesia induction, cooperate with the establishment of intravenous access, arterial catheterization, monitoring of physiological parameters, blood sample collection, and receive fluid preloading;
- During surgery, for patients in the MBMGA group , propofol and remifentanyl will be adjusted according to multimodal brain monitoring indices (WLi and PTi), while for patients in the BIS group, only propofol will be adjusted based on bispectral index and remifentanyl will be adjusted according to anesthesiologists' experience; simultaneously, vital signs, including respiration, body temperature, fluid therapy, blood pressure, and heart rate regulation, will be monitored and managed.
- After surgery, endotracheal tubes will be removed once extubation criteria are met, and patients will be transferred to the PACU, where they will receive routine monitoring and will be discharged from the PACU upon meeting corresponding scoring criteria;
- Participates in follow-ups on the day of surgery and for 1-30 days postoperatively, during which investigators will record the primary outcome and secondary outcomes.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Tianlong Wang, Doctor
- Número de teléfono: 0086139 1052 5304
- Correo electrónico: w_tl5595@hotmail.com
Copia de seguridad de contactos de estudio
- Nombre: Wei Xiao, Doctor
- Número de teléfono: 008613810971299
- Correo electrónico: kitten15@126.com
Ubicaciones de estudio
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Porcelana
- Peking University International Hospital
-
Contacto:
- Lan Yao, Doctor
- Número de teléfono: 008613671010819
- Correo electrónico: yaolan@pkuih.edu.cn
-
Investigador principal:
- Lan Yao
-
Beijing, Beijing Municipality, Porcelana, 10053
- Xuanwu Hospital Capital Medical University
-
Contacto:
- Wei Xiao, Doctor
- Número de teléfono: 008613810971299
- Correo electrónico: kitten15@126.com
-
Investigador principal:
- Tianlong Wang
-
Sub-Investigador:
- Wei Xiao
-
-
Henan
-
Zhengzhou, Henan, Porcelana
- The First Affiliated Hospital of Zhengzhou University
-
Investigador principal:
- Jianjun Yang
-
Contacto:
- Jianjun Yang, Doctor
- Número de teléfono: 008613357739238
- Correo electrónico: jianjunyang1971@163.com
-
-
Hubei
-
Wuhan, Hubei, Porcelana
- Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology
-
Contacto:
- Ailin Luo, Doctor
- Número de teléfono: 008613507122565
- Correo electrónico: alluo@tjh.tjmu.edu.cn
-
Investigador principal:
- Ailin Luo
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
Aged ≥65 years, regardless of gender; Scheduled for elective abdominal surgery with general anesthesia duration (from anesthesia induction to surgery completion) ≥ 2 hours; American Society of Anesthesiologists (ASA) physical status classification of I-III; Body mass index (BMI) of 18.5-29.9 kg/m²; Postoperative hospital stay expected to exceed 72 hours; Compliant with ethical standards, with voluntary signed informed consent.
Exclusion Criteria:
Severe cardiovascular diseases, including:
History of myocardial infarction within the past 6 months; Bradycardia (resting heart rate <50 beats/min); Uncontrolled hypertension (sitting systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥100 mmHg during screening); Sitting systolic blood pressure ≤90 mmHg during screening; History of severe valvular heart disease; Uncontrolled severe respiratory infections: e.g., severe pneumonia, acute bronchitis.
Abnormal liver function: Aspartate Aminotransferase (AST) and/or Alanine Aminotransferase (ALT) ≥2.5×Upper Limit of Normal (ULN), Total Bilirubin (TBIL) ≥1.5×Upper Limit of Normal (ULN); Abnormal renal function: urea or blood urea nitrogen (BUN) ≥1.5×Upper Limit of Normal (ULN), serum creatinine >Upper Limit of Normal (ULN); Admission hemoglobin A1c (HbA1c) ≥6.5% or ≥2 fasting blood glucose measurements ≥180 mg/dl (10 mmol/L) and/or random blood glucose ≥200 mg/dL (≈11.1 mmol/L); Preoperative anemia (Hemoglobin [Hb] ≤90 g/L), thrombocytopenia (Platelet [PLT] ≤80×10⁹/L), hypoproteinemia (Albumin [Alb] ≤30 g/L); History of drug abuse and/or alcoholism within the past 2 years (alcoholism defined as daily average alcohol consumption >2 units, where 1 unit = 360 mL beer or 45 mL 40% ethanol liquor or 150 mL wine); Neurological diseases (e.g., stroke within 6 months, Alzheimer's disease, Parkinson's disease, mental disease, myasthenia gravis) or psychiatric disorders (e.g., schizophrenia, mania, bipolar disorder, delirium), history of long-term use of neuropsychiatric medications, or cognitive impairment; Allergy or contraindication to study medications; Patients refusing or unable to cooperate with the study; Scheduled for pancreatic surgery; Other conditions deemed inappropriate for participation by the investigator.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Multimodal Brain Monitoring Guided Anesthesia Group(MBMGA Group)
The dosage of propofol is adjusted to maintain WLi in the range of 40-70.
While the dosage of remifentanil is adjusted to maintain PTi in the range of 40-70.
When intraoperative pain stimulation suddenly increases ( PTi > 70 ) and lead to increased heart rate and elevated blood pressure, remifentanil 0.5-1 μg / kg will be intravenously injected and observed for 1 min.
If PTi still is > 70, remifentanil 0.5-1 μg / kg will be added again until PTi reached 40-70.
|
During the anesthesia induction phase, the dosage administration is guided by the goal of reducing PTi to the range of 40-70, and tracheal intubation is performed when both PTi and WLI are within 40-70.
In the anesthesia maintenance phase, the propofol dosage is adjusted according to the WLI value to maintain WLI within 40-70, while the remifentanil dosage is adjusted based on the PTi value to keep PTi within 40-70.
In the event of sudden increased intraoperative pain stimulation (PTi > 70) accompanied by tachycardia and hypertension, an intravenous bolus of remifentanil at 0.5-1 μg/kg is administered; after 1 minute of observation, if PTi remains > 70, an additional 0.5-1 μg/kg of remifentanil is given until PTi is brought back to the 40-70 range.
|
|
Comparador activo: Bispectral Index (BIS) Monitoring Guided Anesthesia Group( BIS Group)
The dosage of propofol is adjusted according to the value of BIS, and the BIS is maintained in the range of 40 ~ 60.
The dosage of remifentanil is adjusted according to the experience of anesthesiologists.
The intraoperative remifentanil dosage will be maintained between 0.1 μg/kg/min and 0.3μg/kg/min.When it is highly suspected that the sudden increase of pain stimulation during operation leads to the increase of heart rate and blood pressure, remifentanil 0.5 ~ 1 μg / kg will be given intravenously for 1 min.
If the heart rate and blood pressure level don't improve, remifentanil 0.5 ~ 1 μg / kg is added again until the heart rate and blood pressure have a downward trend and return to the level before the increase.
|
During the anesthesia induction phase, the dosage administration is guided by the goal of reducing BIS to the range of 40-60, with remifentanil supplemented based on clinical experience.
In the anesthesia maintenance phase, the propofol dosage is adjusted according to BIS values to maintain BIS within 40-60, while the remifentanil dosage is adjusted based on anesthesiologists' experience.
When there is a high suspicion of sudden tachycardia and hypertension induced by increased intraoperative pain stimulation, an intravenous bolus of remifentanil at 0.5-1 μg/kg is administered; after 1 minute of observation, if heart rate and blood pressure show no improvement, an additional 0.5-1 μg/kg of remifentanil is given until there is a downward trend in heart rate and blood pressure and they return to pre-stimulation levels.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Incidence of Postoperative Composite Complication
Periodo de tiempo: From post-extubation to postoperative Day 30
|
The incidence of ≥ 1 complication occurred from the extubation to the 30 th day postoperatively The definition of postoperative composite complications refers to the rate of occurrence of one or more complications from the time of anesthesia extubation to postoperative day 7 (or the day of discharge) and within 30 days after surgery.
Postoperative complications are defined as adverse events of Clavien Dindo grade II or higher occurring in any system from postoperative day 1 to day 7 (or the day of discharge) and within 30 days after surgery.
|
From post-extubation to postoperative Day 30
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Incidence of intraoperative stress-induced hyperglycemia
Periodo de tiempo: From anesthesia induction to skin closure, assessed up to 5 minutes after surgery
|
Intraoperative stress hyperglycemia is defined as: A condition diagnosed when a patient meeting all the following criteria: Preoperative glycemic status: Two or more fasting blood glucose measurements < 126 mg/dL (≈7.0 mmol/L) or Random blood glucose < 200 mg/dL (≈11.1 mmol/L) during hospitalization, With concurrent HbA1c < 6.5%; Intraoperative finding: Highest blood glucose level ≥ 140 mg/dL (≈7.8 mmol/L) when measured at: 1 hour after intubation and/or Upon completion of surgery. |
From anesthesia induction to skin closure, assessed up to 5 minutes after surgery
|
|
Incidence of intraoperative composite adverse events
Periodo de tiempo: during operation, assessed up to 5 minutes after surgery
|
Observe and record the incidence of intraoperative composite adverse events . Adverse events include but are not limited to:
|
during operation, assessed up to 5 minutes after surgery
|
|
Blood pressure change immediately after intubation
Periodo de tiempo: at anesthesia induction and immediately after intubation, assessed up to 10 seconds after intubation
|
Record blood pressure before induction and immediately after completion of intubation, and calculate the magnitude of change.
|
at anesthesia induction and immediately after intubation, assessed up to 10 seconds after intubation
|
|
Duration of intraoperative hypotension
Periodo de tiempo: From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery
|
Parameters to be recorded: Duration of intraoperative hypotension; Hypotension is defined as: Mean arterial pressure < 65 mmHg or decrease of mean arterial pressure > 20% from preoperative baseline value. |
From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery
|
|
Total pintraoperative anesthetic/vasoactive drug dosages
Periodo de tiempo: from the anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery
|
Record the dosages of all medications administered during the intraoperative period, including but not limited to: General anesthetics: Propofol, Remifentanil, Sufentanil, Oxycodone Vasoactive agents:
|
from the anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery
|
|
Serum cortisol levels before surgery and 24 hours postoperatively
Periodo de tiempo: From before surgery and 24 hours post-operation
|
Measure serum cortisol concentrations at the following time points: Preoperatively and 24 hours postoperatively |
From before surgery and 24 hours post-operation
|
|
Durations from drug cessation to awake/extubation
Periodo de tiempo: From drug cessation to awake/extubation , assessed up to 2 hours after entering post-anesthsia care unit
|
Duration from anesthesia discontinuation to awake and duration from anesthesia discontinuation to extubation
|
From drug cessation to awake/extubation , assessed up to 2 hours after entering post-anesthsia care unit
|
|
Rate of postoperative Intensive Care Unit/Anesthesia Intensive Care Unit transfer
Periodo de tiempo: From the end of surgery to Discharge, assessed up to 2 weeks after surgery
|
The ratio of postoperative patients requiring transfer to either the Anesthesia Intensive Care Unit or Intensive Care Unit for any clinical indication, to the total number of surgical patients during the same period.
|
From the end of surgery to Discharge, assessed up to 2 weeks after surgery
|
|
Duration to first patient controlled intravenous analgesia pump use
Periodo de tiempo: From the initiation of patient controlled intravenous analgesia pump use to the discontinuation of analgesic pump use, assessed up to 3 days after surgery
|
The duration from the end of surgery until the first activation of the patient controlled intravenous analgesia pump
|
From the initiation of patient controlled intravenous analgesia pump use to the discontinuation of analgesic pump use, assessed up to 3 days after surgery
|
|
Incidence of complications in other organ systems during the follow-up period except stress induced hyperglycemia
Periodo de tiempo: From the start of surgery to 30 days post-operation
|
Follow-up assessments will be performed by a single blinded and certified anesthesia practitioner at postoperative days 1-7 and day 30, with documentation of complications involving: Cardiovascular system; Respiratory system; Digestive system; Nervous system; Urinary system; Infection-related complications,such as wound infection Postoperative complications are defined as adverse events of Clavien Dindo grade II or higher occurring in any system from postoperative day 1 to day 7 (or the day of discharge) and within 30 days after surgery. |
From the start of surgery to 30 days post-operation
|
|
Length of hospital stay
Periodo de tiempo: From patient admission to discharge, assessed up to 2 weeks after surgery
|
the duration of patient stay in hospital
|
From patient admission to discharge, assessed up to 2 weeks after surgery
|
|
Rate of second operation
Periodo de tiempo: From immediately after surgery to 30 days postoperatively
|
Observation and record the rate of secondary surgeries
|
From immediately after surgery to 30 days postoperatively
|
|
Mortality within 30-day postoperatively
Periodo de tiempo: From immediately after surgery to 30 days postoperatively
|
Record the mortality within 30 days postoperatively.
|
From immediately after surgery to 30 days postoperatively
|
|
Incidence of acute myocardial injury
Periodo de tiempo: From anesthesia induction to 24 hours after surgery
|
Measure blood cardiac troponin I level at the following time points: Preoperatively and 24 hours postoperatively, measurement of cardiac troponin I exceeds the 99th percentile upper reference limit
|
From anesthesia induction to 24 hours after surgery
|
|
Incidence of acute kidney injury
Periodo de tiempo: From anesthesia induction to 24 hours after surgery
|
Measure blood creatinine level at the following time points: 1 day before surgery, and 24 hours postoperatively;Acute kidney injury was defined according to the KDIGO criteria as the presence of any of the following: (1) an increase in serum creatinine by ≥26.5 μmol/L (0.3 mg/dL) within 48 hours; (2) an increase in serum creatinine to ≥1.5 times baseline within the previous 7 days; or (3) a urine volume <0.5 mL/kg/h for 6 consecutive hours. |
From anesthesia induction to 24 hours after surgery
|
|
Incidence of postoperative surgical site infection
Periodo de tiempo: From immediately after surgery to 30 days postoperatively
|
surgical site infection refers to the proportion of surgical cases with surgical site infection (SSI) occurring from after surgery to before discharge, relative to the total number of surgical procedures performed on hospitalized patients during the same period.
Postoperative wound infection is defined as an infection related to the surgical procedure and occurring near the surgical site within 30 days after surgery.
Postoperative wound infections include: superficial incisional SSI, deep incisional SSI, and organ/space SSI.
|
From immediately after surgery to 30 days postoperatively
|
|
Heart rate change immediately after intubation
Periodo de tiempo: at anesthesia induction and immediately after intubation, assessed up to 10 seconds after intubation
|
Record heart rate before induction and immediately after completion of intubation, and calculate the magnitude of change.
|
at anesthesia induction and immediately after intubation, assessed up to 10 seconds after intubation
|
|
Duration to postoperative first flatus time
Periodo de tiempo: From the end of surgery to 7 days after surgery
|
Duration to postoperative first flatus time
|
From the end of surgery to 7 days after surgery
|
|
Duration to postoperative first oral intake
Periodo de tiempo: From the end of surgery to 7 days after surgery
|
Duration to postoperative first oral intake
|
From the end of surgery to 7 days after surgery
|
|
Minimum intraoperative mean arterial pressure
Periodo de tiempo: From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery
|
Parameters to be recorded: Minimum intraoperative mean arterial pressure ; |
From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery
|
|
Incidence of hypotension.
Periodo de tiempo: From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery
|
Parameters to be recorded: Incidence of hypotension; Hypotension is defined as: Mean arterial pressure < 65 mmHg or decrease of mean arterial pressure > 20% from preoperative baseline value. |
From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery
|
|
Durations of post-anesthesia care unit stay
Periodo de tiempo: From entering post-anesthesia care unit to post-anesthesia care unit discharge, assessed up to 2 hours after entering post-anesthsia care unit
|
Duration of post-anesthesia care unit stay
|
From entering post-anesthesia care unit to post-anesthesia care unit discharge, assessed up to 2 hours after entering post-anesthsia care unit
|
|
Cumulative postoperative oxycodone dosage
Periodo de tiempo: From the initiation of patient controlled intravenous analgesia pump use to the discontinuation of analgesic pump use, assessed up to 3 days after surgery
|
Cumulative postoperative oxycodone dose
|
From the initiation of patient controlled intravenous analgesia pump use to the discontinuation of analgesic pump use, assessed up to 3 days after surgery
|
|
The duration of intraoperative deep sedation
Periodo de tiempo: from anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery
|
The duration of intraoperative wavelet index below 40 or Bispectral Index below 40
|
from anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery
|
|
The duration of intraoperative inadequate analgesia
Periodo de tiempo: from anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery
|
The duration of intraoperative pain threshold index higher than 70
|
from anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery
|
|
Scores of Intake, Feeling nauseated, Emesis, physical Exam, and Duration of symptoms at 72 hours after surgery
Periodo de tiempo: at 72 hours after surgery
|
Scores of Intake, Feeling nauseated, Emesis, physical Exam, and Duration of symptoms at 72 hours after surgery, Intake, Feeling nauseated, Emesis, physical Exam, and Duration of symptoms is a scoring system to evaluate the postoperative gastrointestinal function, if the score is higher than 6, it indicating gastrointestinal dysfunction.
|
at 72 hours after surgery
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Tianlong Wang, Doctor, Xuanwu Hospital, Beijing
Publicaciones y enlaces útiles
Publicaciones Generales
- Lewis SR, Pritchard MW, Fawcett LJ, Punjasawadwong Y. Bispectral index for improving intraoperative awareness and early postoperative recovery in adults. Cochrane Database Syst Rev. 2019 Sep 26;9(9):CD003843. doi: 10.1002/14651858.CD003843.pub4.
- Lau CS, Chamberlain RS. Enhanced Recovery After Surgery Programs Improve Patient Outcomes and Recovery: A Meta-analysis. World J Surg. 2017 Apr;41(4):899-913. doi: 10.1007/s00268-016-3807-4.
- American Diabetes Association Professional Practice Committee. 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2025. Diabetes Care. 2025 Jan 1;48(1 Suppl 1):S321-S334. doi: 10.2337/dc25-S016.
- You J, Chen X, Rong Y, Pan S, Liu T, Xie Y. Application value of different frailty assessment tools in older patients undergoing major abdominal surgery. Exp Gerontol. 2025 Oct 1;209:112852. doi: 10.1016/j.exger.2025.112852. Epub 2025 Jul 29.
- Trocheris-Fumery O, Flet T, Scetbon C, Tarpin P, Meynier J, Badaoui R, De Broca B, Sabbagh C, Regimbeau JM, De Sousa P, Foulon A, Josse E, Dupont H, Bar S, Abou-Arab O. Early Use of Norepinephrine in High-risk Patients Undergoing Major Abdominal Surgery: A Randomized Controlled Trial. Anesthesiology. 2025 Nov 1;143(5):1160-1170. doi: 10.1097/ALN.0000000000005704. Epub 2025 Aug 4.
- Zhang Y, Yan R, Kurexi A, Yuan T, Taati Z, Mijiti M, Li D, Wei F. The relationship between preoperative SPPB scores and 30-day postoperative pulmonary complications in elderly patients undergoing elective major abdominal surgery. BMC Surg. 2025 Oct 28;25(1):507. doi: 10.1186/s12893-025-03260-6.
- Bieze M, McGinn R, Berrio-Valencia M, Talarico R, Martel G, McCluskey SA, McIsaac DI. Temporal trends in postoperative outcomes after major abdominal surgery: a population-based cohort study. Br J Anaesth. 2026 Jan;136(1):237-246. doi: 10.1016/j.bja.2025.08.030. Epub 2025 Oct 23.
- Gameiro J, Neves JB, Rodrigues N, Bekerman C, Melo MJ, Pereira M, Teixeira C, Mendes I, Jorge S, Rosa R, Lopes JA. Acute kidney injury, long-term renal function and mortality in patients undergoing major abdominal surgery: a cohort analysis. Clin Kidney J. 2016 Apr;9(2):192-200. doi: 10.1093/ckj/sfv144. Epub 2016 Jan 18.
- Teixeira C, Rosa R, Rodrigues N, Mendes I, Peixoto L, Dias S, Melo MJ, Pereira M, Bicha Castelo H, Lopes JA. Acute kidney injury after major abdominal surgery: a retrospective cohort analysis. Crit Care Res Pract. 2014;2014:132175. doi: 10.1155/2014/132175. Epub 2014 Feb 24.
- Zhang W, Cheng Y, Zhang L, Wei Y, Xie H, Huang J. Association between emergence delirium and brain status parameters in children undergoing general anesthesia: A prospective observational study. Paediatr Anaesth. 2024 Feb;34(2):130-137. doi: 10.1111/pan.14779. Epub 2023 Oct 3.
- Zhang JW, Lv ZG, Kong Y, Han CF, Wang BG. Wavelet and pain rating index for inhalation anesthesia: A randomized controlled trial. World J Clin Cases. 2020 Nov 6;8(21):5221-5234. doi: 10.12998/wjcc.v8.i21.5221.
- Funcke S, Pinnschmidt HO, Wesseler S, Brinkmann C, Beyer B, Jazbutyte V, Behem CR, Trepte C, Nitzschke R. Guiding Opioid Administration by 3 Different Analgesia Nociception Monitoring Indices During General Anesthesia Alters Intraoperative Sufentanil Consumption and Stress Hormone Release: A Randomized Controlled Pilot Study. Anesth Analg. 2020 May;130(5):1264-1273. doi: 10.1213/ANE.0000000000004388.
- Wu L, Wang S, Wang Y, Zhang K, Bai J, Zheng J. Prediction of Hemodynamic Reactivity by Electroencephalographically Derived Pain Threshold Index in Children Undergoing General Anesthesia: A Prospective Observational Study. J Pain Res. 2019 Dec 3;12:3245-3255. doi: 10.2147/JPR.S231596. eCollection 2019.
- Shen H, Wang S, Zhang C, Gao W, Cui X, Zhang Q, Lang Y, Ning M, Li T. Association of hyperglycemia ratio and ventricular arrhythmia in critically ill patients admitted to the intensive care unit. BMC Cardiovasc Disord. 2023 Apr 28;23(1):215. doi: 10.1186/s12872-023-03208-9.
- Yu Y, Wang H, Wei L, Gao Y, Yan N, Chu J, Li H. Assessing the use of the Index of Consciousness (IoC) as a monitoring tool for the sedative effects of ciprofol during general anesthesia induction: a prospective observational study. Perioper Med (Lond). 2025 Jan 6;14(1):1. doi: 10.1186/s13741-024-00484-7.
- Chung CKE, Poon CCM, Irwin MG. Peri-operative neurological monitoring with electroencephalography and cerebral oximetry: a narrative review. Anaesthesia. 2022 Jan;77 Suppl 1:113-122. doi: 10.1111/anae.15616.
- Fu G, Xu L, Chen H, Lin J. State-of-the-art anesthesia practices: a comprehensive review on optimizing patient safety and recovery. BMC Surg. 2025 Jan 20;25(1):32. doi: 10.1186/s12893-025-02763-6.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- Linyanshen[2025]075-004-xz-1
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Marco de tiempo para compartir IPD
Criterios de acceso compartido de IPD
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .